Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-24 @ 10:48 PM
NCT ID: NCT06385769
Eligibility Criteria: Inclusion Criteria: * Patients aged 40 and above with stable ischemic or hemorrhagic stroke. * Patients with neurogenic detrusor overactivity symptoms accompanied by urinary incontinence complaints and a urinary frequency of 9 or more. * Patients diagnosed with detrusor overactivity on urodynamic evaluation. * Patients with hemiplegia lasting between 30 days and 1 year. * Ability to understand procedures, benefits, and potential side effects. * Patients scoring 22 or above on the Mini Mental Test. Exclusion Criteria: * Patients with post-stroke neurogenic detrusor overactivity receiving or previously received pharmacological treatment. * Patients using intermittent catheterization or permanent catheterization as a bladder emptying method. * Patients with a history of urinary incontinence and/or urinary retention before stroke. * History of past urogynecological surgery. * Presence of urinary tract infection, bladder tumor, or cardiac pacemaker. * Significant fluid infusion requirement affecting urination or use of medication affecting bladder function. * Patients who have received botulinum toxin injection for post-stroke neurogenic detrusor overactivity. * Patients with postvoid residual volume above 150 mL.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT06385769
Study Brief:
Protocol Section: NCT06385769